Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Covalent Warheads Targeting Cysteine Residue: The Promising Approach in Drug Development
Fangjiao Huang, Xiaoli Han, Xiaohui Xiao, et al.
Molecules (2022) Vol. 27, Iss. 22, pp. 7728-7728
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Michael Acceptors as Anti-Cancer Compounds: Coincidence or Causality?
Celia María Curieses Andrés, José Manuel Pérez de la Lastra, Elena Bustamante Munguira, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6099-6099
Open Access | Times Cited: 13
Recent Advances on Targeting Proteases for Antiviral Development
Pedro Henrique Oliveira Borges, Sabrina Baptista Ferreira, Floriano Paes Silva
Viruses (2024) Vol. 16, Iss. 3, pp. 366-366
Open Access | Times Cited: 9
Structural Requirements of Isoform-Specific Inhibitors of Akt: Implications in the Development of Effective Cancer Treatment Strategies
Tenzin Adon, Syamal D. Bhattacharya, SubbaRao V. Madhunapantula, et al.
European Journal of Medicinal Chemistry (2025), pp. 117334-117334
Closed Access | Times Cited: 1
Modern Cyclopropanation via Non‐Traditional Building Blocks
Christopher B. Kelly, Léa Thai‐Savard, Jiefeng Hu, et al.
ChemCatChem (2024) Vol. 16, Iss. 14
Closed Access | Times Cited: 7
Recharacterization of RSL3 reveals that the selenoproteome is a druggable target in colorectal cancer
Stephen L. DeAngelo, Liang Zhao, Sofia Dziechciarz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Discovery and Preclinical Characterization of BIIB129, a Covalent, Selective, and Brain-Penetrant BTK Inhibitor for the Treatment of Multiple Sclerosis
Martin Himmelbauer, Bekim Bajrami, Rebecca Basile, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 8122-8140
Open Access | Times Cited: 5
A Near-Infrared Fluorescent Dye with Tunable Emission Wavelength and Stokes Shift as a High-Sensitivity Cysteine Nanoprobe for Monitoring Ischemic Stroke
Yuesong Wang, Mingxi Li, Haoli Yu, et al.
ACS Nano (2024) Vol. 18, Iss. 24, pp. 15978-15990
Closed Access | Times Cited: 5
Covalent drug – An emerging framework for targeted drug development
Ritesh Bhole, Govinda O. Joshi, Harshad S. Kapare, et al.
Results in Chemistry (2024) Vol. 8, pp. 101615-101615
Open Access | Times Cited: 5
Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions
Ahmed M. Shawky, Faisal A. Almalki, Hayat Ali Alzahrani, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116704-116704
Closed Access | Times Cited: 5
UBE2N: Hope on the Cancer Front, How to Inhibit This Promising Target Prospect?
Florian Schwalen, Côme Ghadi, Léonie Ibazizene, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Chemical Probes for Studying the Eukaryotic Translation Initiation Factor 4E (eIF4E)-Regulated Translatome in Cancer
Rachel L. O’Rourke, Amanda L. Garner
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 3, pp. 621-635
Closed Access
DNA-encoded Libraries with Covalent Warheads
Sixiu Liu, Rui Jin, Zhiqiang Duan, et al.
Royal Society of Chemistry eBooks (2025), pp. 119-133
Closed Access
Small molecules for Kirsten rat sarcoma viral oncogene homolog mutant cancers: Past, present, and future
Peiliang Dong, Jiating Ni, Xinyue Zheng, et al.
European Journal of Pharmacology (2025), pp. 177428-177428
Closed Access
Probing the Effect of Protein and Inhibitor Conformational Flexibility on the Reaction of Rocelitinib-Like Covalent Inhibitors of Epidermal Growth Factor Receptor. A Quantum Mechanics/Molecular Mechanics Study
Orathai Kaewkham, Duangkamol Gleeson, Poowadon Fukasem, et al.
Journal of Chemical Information and Modeling (2025)
Open Access
Identification of lead small molecules for the design and development of potent severe acute respiratory syndrome coronavirus 2 main protease inhibitors
Elvis Awuni
Journal of Chemical Research (2025) Vol. 49, Iss. 2
Open Access
Caffeic acid activates Nrf2 enzymes, providing protection against oxidative damage induced by ionizing radiation
Juan Yao, Yuanyuan Liu, Hang Lin, et al.
Brain Research Bulletin (2025), pp. 111325-111325
Open Access
Multiple Strategies to Develop Small Molecular KRAS Directly Bound Inhibitors
Xile Zhou, Yang Ji, Jinming Zhou
Molecules (2023) Vol. 28, Iss. 8, pp. 3615-3615
Open Access | Times Cited: 11
Covalent inhibitors: An ambitious approach for the discovery of newer oncotherapeutics
Rameshwar S. Cheke, Prashant S. Kharkar
Drug Development Research (2023) Vol. 85, Iss. 1
Open Access | Times Cited: 11
AI-driven covalent drug design strategies targeting main protease (m pro ) against SARS-CoV-2: structural insights and molecular mechanisms
Mohammad Hossein Haghir Ebrahim Abadi, Abdulrahman Ghasemlou, Fatemeh Bayani, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-29
Closed Access | Times Cited: 4
Computer-aided drug design for the double-membrane vesicle pore complex inhibitors against SARS-CoV-2
Han Wang, Rui Zhou, Ruolan Wang, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Indole-Acrylonitrile Derivatives as Potential Antitumor and Antimicrobial Agents—Synthesis, In Vitro and In Silico Studies
Anita Kornicka, Karol Gzella, Katarzyna Garbacz, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 918-918
Open Access | Times Cited: 10
Late‐Stage C−H Activation of Drug (Derivative) Molecules with Pd(ll) Catalysis
Su Yong Shim
Chemistry - A European Journal (2023) Vol. 29, Iss. 71
Open Access | Times Cited: 9
Design of a Lead-Like Cysteine-Targeting Covalent Library and the Identification of Hits to Cys55 of Bfl-1
Simon C. C. Lucas, Alexander G. Milbradt, J. Henry Blackwell, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 13, pp. 11209-11225
Closed Access | Times Cited: 3
Recent advances in the design of small molecular drugs with acrylamides covalent warheads
Luxia Liang, Ze Zhang, Qidong You, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117902-117902
Closed Access | Times Cited: 3
Structural analysis of the coronavirus main protease for the design of pan-variant inhibitors
Runchana Rungruangmaitree, Sakao Phoochaijaroen, Aunlika Chimprasit, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top